Madison Dearborn Partners (MDP)
PE
1992
$19 000 M
Chicago, Illinois, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
MDP has a history in Chicago that dates back to the early 1980s when its founders built a $2.6 billion management buyout and venture capital portfolio at First Chicago Venture Capital. Since the founders established MDP as an independent firm in 1992, the firm has raised eight funds with aggregate capital of approximately $28 billion, and has completed investments in more than 150 companies.
Madison Dearborn Partners, LLC ("MDP") is a leading private equity investment firm based in Chicago that, since its formation in 1992, has raised aggregate capital of approximately $28 billion and has completed over 150 investments. MDP seeks to invest in partnership with outstanding management teams to drive growth and achieve significant long-term value appreciation at its portfolio companies and for its limited partner investors globally. A flexible investment approach, encompassing both buyout and growth equity investments, expertise in five dedicated industry verticals and a focus on upper middle market and middle market companies have been and continue to be key tenets of MDP’s investment strategy. MDP’s team is among the most experienced in the private equity industry, and its five dedicated industry verticals include: Basic Industries; Business & Government Software and Services; Financial & Transaction Services; Health Care; and Telecom, Media & Technology Services. For more information, please visit https://www.mdcp.com.
Industry
Region of investment
Madison Dearborn Partners (MDP) Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Madison Dearborn Partners Fund VIII
|
Private Equity (PE)
|
Financial Services
Fintech
Healthcare Services
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$5000 M
|
June 2021
|
|
Madison Dearborn Capital Partners VII
|
Private Equity (PE)
|
Consumer Products
Consumer Services (B2C)
Financial Services
Fintech
Healthcare Services
Technology
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$4400 M
|
June 2016
|
